No Data
No Data
Jilin Jian Yisheng Pharmaceutical: Half-year report for the year 2024.
Jilin Jian Yisheng Pharmaceutical: Summary of Half-Year Report in 2024.
Jilin Jian Yisheng Pharmaceutical (002566.SZ): The net income in the first half of the year was 33.3358 million yuan, a year-on-year decrease of 29.71%.
Gelonghui August 23 | Jilin Jian Yisheng Pharmaceutical (002566.SZ) released its semi-annual report for 2024, with a total operating income of 0.348 billion yuan during the reporting period, a decrease of 25.90% year-on-year; net income attributable to the shareholders of the listed company was 33.3358 million yuan, a decrease of 29.71% year-on-year; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 20.3051 million yuan, a decrease of 45.04% year-on-year; basic earnings per share were 0.1007 yuan.
As of August 10th, 2024, the total number of shareholders of Jilin Jian Yisheng Pharmaceutical (002566.SZ) was 23,565.
Jilin Jian Yisheng Pharmaceutical (002566.SZ) stated on the investor interaction platform on August 13th that as of August 10th, 2024, the total number of shareholders in the company was 23,565.
As of July 19, 2024, the total number of shareholders for Jilin Jian Yisheng Pharmaceutical (002566.SZ) is 23,832.
On July 24th, Gelunhui reported that as of July 19th, 2024, the total number of shareholders of Jilin Jian Yisheng Pharmaceutical (002566.SZ) was 23,832.
As of July 10th, the total number of shareholders for Jilin Jian Yisheng Pharmaceutical (002566.SZ) is 23,693.
Jilin Jian Yisheng Pharmaceutical (002566.SZ) stated on the investor interaction platform on July 15th that as of July 10th, 2024, the total number of shareholders was 23693.
No Data
No Data